GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Lytix Biopharma AS (OSL:LYTIX) » Definitions » Interest and Commission Paid

Lytix Biopharma AS (OSL:LYTIX) Interest and Commission Paid


View and export this data going back to 2021. Start your Free Trial

What is Lytix Biopharma AS Interest and Commission Paid?

Interest and Commission Paid only applicable to companies reporting Cash Flow from Operations in direct method.


Lytix Biopharma AS Business Description

Traded in Other Exchanges
Address
Sandakerveien 138, Oslo, NOR, 0484
Lytix Biopharma AS is a clinical-stage biotech company engaged in developing cancer immunotherapies aimed at activating the patient's immune system to fight cancer. Its products, LTX-401, and LTX-315 are in the pipeline.